undamentalytics Newsletter
Sign in

Neuraxis, Inc balance sheet

At the end of fiscal 2025, Neuraxis, Inc had total assets of $6.4m, total liabilities of $3.0m and shareholders' equity of $3.4m. It held $5.0m in cash against $148,293 of debt: net cash of $4.8m.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents254793,6974,9658,322
Receivables17473245196433
Inventory482144257277
Total current assets4772434,2665,7339,414
Total assets1,4815094,7586,4049,996
Accounts payable1,5921,204597139792
Total current liabilities6,9781,8862,4332,7923,096
Short-term debt—14815414843
Long-term debt228————
Total debt22818715414843
Total liabilities7,0541,9132,6903,0053,261
Shareholders' equity−5,574−1,4032,0683,3996,735
Net debt (negative = net cash)−25108−3,543−4,817−8,280
Shares outstanding2m—7m11m12m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: LUCD vs NRXSMCTA vs NRXSBIAF vs NRXS

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Neuraxis, Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neuraxis, Inc.